Becky D.

Schererville, IN

Becky’s Journey With COPD Treatment

Age: 62 | Location: Schererville, IN | Condition: COPD

Becky D’s COPD made living her life challenging. She felt frustrated with her lack of improvement and with the medications she was prescribed. Becky’s sister went online and found the Lung Institute after searching for how to improve lung function. Before treatment, Becky always counted her steps, thought about distance and looked for ramps. If she felt like going somewhere was going to be difficult, she wouldn’t go. After treatment, Becky says that she can do anything. She continues to reach her goals, such as walking across the soccer field to watch her grandchildren play soccer. Becky looks forward to attending her son’s wedding, dancing and enjoying the whole evening. Even though she still has COPD and she understands that everyone is different, Becky says that treatment at the Lung Institute has “made a world of difference.”

Becky brought her life back within reach, and so can you. If you would like to see results like Becky and learn more, please contact one of our patient coordinators or call us at 888-745-6697.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.